Bevacizumab (Avastin(®)) for the management of anterior chamber neovascularization and neovascular glaucoma

PURPOSE: To establish the efficacy and safety of intravitreal bevacizumab in reducing iris and anterior chamber angle neovascularization and managing neovascular glaucoma. DESIGN: Prospective interventional case series. PATIENT AND METHODS: Eleven eyes of 11 patients with iris and anterior chamber a...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Brouzas, Dimitrios, Charakidas, Antonios, Moschos, Marilita, Koutsandrea, Chryssanthi, Apostolopoulos, Michael, Baltatzis, Stefanos
格式: Artigo
語言:Inglês
出版: Dove Medical Press 2009
主題:
Case Report
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC2801638/
https://ncbi.nlm.nih.gov/pubmed/20054417
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍